Key result
Higher heart rate-adjusted augmentation index (AIx@75) was independently associated with an increased likelihood of undergoing percutaneous coronary intervention in patients with suspected coronary artery disease.
Why the study?
Does the augmentation index predict the need for percutaneous coronary intervention in patients with suspected CAD and high Framingham risk scores?
Observational (n=232)
No
Does the augmentation index predict the need for percutaneous coronary intervention in patients with suspected CAD and high Framingham risk scores?
Augmentation index adjusted for heart rate (AIx@75) is associated with clinical CAD severity and the need for revascularization in high-risk patients.
Answers are grounded in this paper and cite their sources.
May support AIx@75 evaluation in suspected CAD; leaves open incremental value over Framingham scores before clinical adoption.
BACKGROUND: This study analyzed PWAs in patients with high Framingham risk scores to determine whether PWA is predictive of coronary artery disease (CAD) severity and percutaneous coronary intervention (PCI) treatment. METHODS: In total, 310 patients were screened due to suspected CAD; 78 were excluded due to PCI history (32), atrial fibrillation (11), or acute myocardial infarction (35). The augmentation index (AIx) was analyzed immediately before coronary angiography. PCI was performed in 73 (31.5 %) patients. RESULTS: The mean AIx, adjusted by heart rate (AIx@75) was different for each clinical diagnosis in the PCI group (stable angina, 30.6 ± 7.7 %; silent ischemia, 30.2 ± 8.6 %; unstable angina, 38.5 ± 8.5 %; p = 0.026). The 10-year estimate of CVD risk, based on the Framingham heart score, was 25.3 ± 6.5 % and the mean AIx@75 was 31.6 ± 8.5 % in the PCI group, significantly higher than in the non-PCI group (18.8 ± 10.2 %, p < 0.001; 27.2 ± 9.0 %, p = 0.006, respectively). An inverse correlation was observed between the minimal luminal area and AIx@75 (rho = -0.559, p = 0.010, n = 20). In ROC curve analysis of multivariate logistic regression model, higher HDL, medication of hypertension, and higher body mass index were associated with non-PCI and higher AIx@75 was associated with PCI (area under the curve, 0.764; 95 % CI: 0.701 to 0.819, z = 8.005; p <0.001). CONCLUSIONS: The AIx@75 seemed to reflect the clinical severity of CAD and was associated with PCI in patients with a high Framingham risk score.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2015) conducted an observational in Suspected coronary artery disease (n=232). Higher heart rate-adjusted augmentation index (AIx@75) vs. Lower AIx@75 was evaluated on Percutaneous coronary intervention (PCI) (OR 1.048, 95% CI 1.009-1.088, p=0.015). Higher heart rate-adjusted augmentation index (AIx@75) was independently associated with an increased likelihood of undergoing percutaneous coronary intervention in patients with suspected coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: